On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for its Acculaﾙ SARS-CoV-2 Test, which gives COVID-19 diagnostic results in 30 minutes. The Accula SARS-CoV-2 Test is a visually read test using polymerase chain reaction (PCR) technology to detect SARS-CoV-2 (the virus responsible for COVID-19) via throat and nasal swab samples.

Mesa Biotech’s technology was developed at Los Alamos National Lab.